[Use of Betaxolol in patients with glaucoma and chronic nonspecific diseases of the respiratory system].
Betaxolol is a new antiglaucomatous drug which is blocking solely the beta 1 receptors and in contrast to Timolol may be applied in persons with spastic conditions of the bronchi. It has been given twice daily to 9 persons with glaucoma and long standing bronchial asthma. In the period of observation (1.5-6.5 months) neither of the examined patients showed any deterioration of the spirometric indexes nor bradycardia. In a part of the patients the intraocular pressure was normalized only by application of Betaxolol; over one half of them however needed additionally the use of miotics.
Swietliczko
I
I
Rojek
A
A
Sempińska-Szewczyk
J
J
Toczyska-Rozentryt
E
E
D000368:Aged; D015784:Betaxolol / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D005260:Female; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects* / Q000502:physiology; D008173:Lung Diseases, Obstructive / Q000150:complications* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions
D009883:Ophthalmic Solutions; D015784:Betaxolol
Zastosowanie betaxololu u chorych na jaskre i przewsklekłoe nieswoiste choroby układu oddechowego.